These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26999330)

  • 1. Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma.
    Bolomsky A; Schreder M; Hübl W; Zojer N; Hilbe W; Ludwig H
    Leuk Lymphoma; 2016 Nov; 57(11):2516-25. PubMed ID: 26999330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
    Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
    Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIG Th1 chemokine in Vitiligo.
    Elia G
    Clin Ter; 2018; 169(6):e303-e307. PubMed ID: 30554253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatomyositis and MIG.
    Ragusa F
    Clin Ter; 2019; 170(2):e142-e147. PubMed ID: 30993311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIG in Crohn's disease.
    Caruso C
    Clin Ter; 2019; 170(3):e206-e210. PubMed ID: 31173051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages.
    Nishioka Y; Manabe K; Kishi J; Wang W; Inayama M; Azuma M; Sone S
    Clin Exp Immunol; 2007 Aug; 149(2):317-26. PubMed ID: 17550373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease.
    Romagnani P; Rotondi M; Lazzeri E; Lasagni L; Francalanci M; Buonamano A; Milani S; Vitti P; Chiovato L; Tonacchera M; Bellastella A; Serio M
    Am J Pathol; 2002 Jul; 161(1):195-206. PubMed ID: 12107104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoidosis and the Th1 chemokine MIG.
    Ragusa F
    Clin Ter; 2018; 169(6):e308-e313. PubMed ID: 30554254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.
    Egesten A; Eliasson M; Olin AI; Erjefält JS; Bjartell A; Sangfelt P; Carlson M
    Int J Colorectal Dis; 2007 Dec; 22(12):1421-7. PubMed ID: 17703315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and role of MIG/CXCR3 axis in mantle cell lymphoma.
    Zhu MX; Wan WL; Hong Y; Wang YF; Dong F; Jing HM
    Exp Cell Res; 2020 Dec; 397(2):112365. PubMed ID: 33197439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MIG Chemokine in Inflammatory Myopathies.
    Paparo SR
    Clin Ter; 2019; 170(1):e55-e60. PubMed ID: 30789198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 diabetes and MIG.
    Gonnella D
    Clin Ter; 2019; 170(6):e465-e471. PubMed ID: 31696911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIG in psoriatic arthritis.
    Elia G
    Clin Ter; 2018; 169(6):e297-e302. PubMed ID: 30554252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis.
    Chung W; Lee K; Jung Y; Kim Y; Park J; Sheen S; Lee J; Kang D; Park K
    Int J Tuberc Lung Dis; 2015 Dec; 19(12):1476-84. PubMed ID: 26614189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydophila pneumoniae induces production of the defensin-like MIG/CXCL9, which has in vitro antichlamydial activity.
    Balogh EP; Faludi I; Virók DP; Endrész V; Burián K
    Int J Med Microbiol; 2011 Mar; 301(3):252-9. PubMed ID: 21056004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives.
    Chuang YH; Lian ZX; Cheng CM; Lan RY; Yang GX; Moritoki Y; Chiang BL; Ansari AA; Tsuneyama K; Coppel RL; Gershwin ME
    J Autoimmun; 2005 Sep; 25(2):126-32. PubMed ID: 16243485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment.
    Neo SY; Lundqvist A
    Adv Exp Med Biol; 2020; 1231():45-51. PubMed ID: 32060845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of IFN-inducible CXCR3 ligands predicts poor prognosis in patients with non-metastatic clear-cell renal cell carcinoma.
    Liu W; Liu Y; Fu Q; Zhou L; Chang Y; Xu L; Zhang W; Xu J
    Oncotarget; 2016 Mar; 7(12):13976-83. PubMed ID: 26910919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mig chemokine in primary biliary cirrhosis.
    Mazzi V
    Clin Ter; 2019; 170(3):e211-e215. PubMed ID: 31173052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.